Connect with us

IT Industry

MicroVision Receives Nasdaq Global Market Listing Deficiency Notice

GlobeNewswire

Published

on

Reading Time: 3 minutes

REDMOND, Wash., June 14, 2019 (GLOBE NEWSWIRE) — MicroVision, Inc. (Nasdaq: MVIS) announced today that it received a notice on June 13, 2019 from The Nasdaq Stock Market advising the company that for 30 consecutive business days preceding the date of the notice, the bid price of the company’s common stock had closed below the $1.00 per share minimum required for continued listing on The Nasdaq Global Market pursuant to Nasdaq’s listing requirements. In accordance with Nasdaq’s listing rules, the company has 180 calendar days, or until December 10, 2019, to regain compliance with this requirement. This notification is simply a notice of deficiency, not of imminent delisting, and has no current effect on the listing or trading of MicroVision’s common stock on The Nasdaq Global Market at this time.

During the 180-day compliance period, MicroVision can regain compliance if the bid price of its common stock closes at $1.00 or higher for a minimum of ten consecutive business days. If the company does not regain compliance by December 10, 2019, Nasdaq will notify the company that its securities are subject to delisting.

The company is monitoring the bid price for its common stock. The company continues to execute its business plan and will consider other actions that it may take in order to regain compliance with the listing requirements.

About MicroVision

MicroVision is the creator of PicoP® scanning technology, an ultra-miniature sensing and projection solution based on the laser beam scanning methodology pioneered by the company. MicroVision’s platform approach for this sensing and display solution means that its technology can be adapted to a wide array of applications and form factors. We combine our hardware, software, and algorithms to unlock value for our customers by providing them a differentiated advanced solution for a rapidly evolving, always-on world.

Extensive research has led MicroVision to become an independently recognized leader in the development of intellectual property. MicroVision’s IP portfolio has been recognized by the Patent Board as a top 50 IP portfolio among global industrial companies and has been included in the Ocean Tomo 300 Patent Index. The company is based in Redmond, Washington.

MicroVision and PicoP are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Forward-looking Statements

Certain statements contained in this release, including those relating to MicroVision’s expectations, intentions or strategies, are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in our forward-looking statements include the following: the risk that MicroVision may not regain compliance with the continued listing standards of the Nasdaq Stock Market; capital market risks; our ability to raise additional capital when needed; market acceptance of our technologies and products, and for products incorporating our technologies; the failure of our commercial partners to perform as expected under our agreements; our ability to identify parties interested in paying any amounts or amounts we deem desirable for the purchase or license of intellectual property assets; our or our customers’ failure to perform under open purchase orders; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims; and other risk factors identified from time to time in the company’s SEC reports, including the company’s Annual Report on Form 10-K filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect us. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect us to a greater extent than indicated. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

Additional Information

Additional information relating to MicroVision can be found on EDGAR at www.sec.gov.

Contact

David H. Allen
Darrow Associates, Inc.
408.427.4463
dallen@darrowir.com 

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

IT Industry

Chitosan Market Value To Reach Around US$ 22 Billion by 2026

GlobeNewswire

Published

on

Reading Time: 3 minutes

The global chitosan market value is poised to reach around USD 22 billion by 2026 and will grow at CAGR above 20.2 % over the forecast time frame 2019 to 2026

LOS ANGELES, June 14, 2019 (GLOBE NEWSWIRE) — Acumen Research and Consulting, Recently Published Report on “Chitosan Market (By Application: Water Treatment, Food & Beverage, Cosmetics, Pharmaceutical & Biomedical, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026.”

Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1446

Chitosan is a type of chitin that is the most important component in the marine animal exoskeleton. The marine shell waste, such as squid, shrimp, krill and crabs, is manufactured commercially. Chitosan is used in a wide range of end use sectors like food, chemicals, food, food and drug products, agriculture, cosmetics and more. However, water processing, bio-medicine, pharmaceuticals, cosmetics, food & beverage are the main end-use sectors.

The market is driven by the increased range of applications in cosmetics, water therapy for impurity removal and the medical industries. In addition, increasing demand is driving the market growth of biofunded chemicals and fewer fresh water resources. Because of the favorable prospects of the pharmaceutical industry in the area North America is anticipated to be a market leader in the near future.

In conjunction with public initiatives, increased demand from the cosmetic sector and the widening implementation of wastewater treatment also drive development. The demand for chitosan for different apps is anticipated to grow in the next few years. In order to propel the product demand, increasing waste water treatment needs are expected to be addressed in sectors such as textiles, milk products, paper & pulp, metal cutting and chemical. As a consequence, the growing demand for products is likewise expected to increase market growth as a result of water treatment and the stringent rules on wastewater disposal.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/chitosan-market

The chitosan industry’s key variables are the rich supply of raw materials and the evolving apps in different sections of end use. Continuing R&D operations centered on the search for new uses for chitosan and the development of current technologies are also anticipated to contribute to chitosan market development during the period under examination. Nevertheless, elevated manufacturing costs of chitosan and its derivatives as well as product inconsistency could hinder market growth owing to seasonal, regional and chemical changes.

Wastewater Treatment Applications Driving Demand

Some of the main driving forces for demand in the worldwide chitosan industry are unique and helpful characteristics of chitosan, extensive supply of raw products and increased understanding of its health advantages. On the other side, the chitosan market is hampered by stringent laws relating to the cultivation of shrimps, striking drawbacks in drug delivery systems and instability in certain other areas. As an additional opportunity in this industry, the analyst has expected the development of chitosan from non-aquatic sources.

Key Findings

Increasing demand and growing preferences for natural-derived products by pharmaceutics and cosmetics producers are anticipated to make North America the fastest-growing region. 

A CAGR of approximately 21 percent is expected to grow in Canada’s pharmaceutical industry in due course to increase R&D in tissue engineering applications in product.

Browse all official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

Explore Our Market Blog@ https://www.acumenresearchandconsulting.com/blogs

Key Players & Strategies

FMC Corp., Qingdao Yunzhou Biochemistry Co., Golden Shell Pharmaceutical Co., Heppe Medical Chitosan GmbH Ltd., are some of the major businesses on the market. Major enterprises are faced with comparatively less national competition. However, over the forecast period, fast development of the Japanese and Chinese markets will hinder their development. In addition, the growing amount of market entrants is likely to intensify competitiveness over the forecast period, owing to an simple manufacturing method and increased product demand.

Manufacturers are more focused on lowering product costs while increasing output and quality to maintain and reinforce their industrial presence. Initiatives to develop the fishing sector in multiple nations like India are anticipated to increase the accessibility of raw materials. Current study by governments and private organisations in these areas should also promote the entry of fresh enterprises on the market and thus intensify competition between industries.

Acumen Research and Consulting Enters Partnership with MARKETWATCH, Click Here

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1446

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1446

If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

For Latest Update Follow Us:

https://twitter.com/AcumenRC

https://www.facebook.com/acumenresearchandconsulting

https://www.linkedin.com/company/acumen-research-and-consulting/  

Continue Reading

IT Industry

Lift & Co. cannabis experts are available to help media navigate new cannabis products and regulations coming to market

GlobeNewswire

Published

on

Reading Time: 4 minutes

The federal government just announced regulations allowing new cannabis products to come to market. Navigating what these new products may be and what the regulations mean for Canadian consumers can be challenging. Lift & Co., the company behind CannSell retail training, is here to help.  

TORONTO, June 14, 2019 (GLOBE NEWSWIRE) — Lift & Co. Corp. (“Lift & Co.” or the “Company”) (TSXV: LIFT) (OTCQB: LFCOF) cannabis experts including our CEO Matei Olaru, VP Strategy Nick Pateras and CannSell experts are available for interview, comment or background to media covering the new cannabis products and the regulations announced today by the federal government.

“In terms of boosting the market, the legalization of these product formats could be even more significant than the initial phase of legalization,” says Nick Pateras, Vice President of Strategy for Lift & Co. “These new formats will be the catalyst for market acceleration and are paramount to effectively shifting demand into regulated channels.”

“These new cannabis products will bring a whole new consumer segment into the sector. Our recent partnered study on edibles indicates 1.5 million in new consumers in the first year,” said Matei Olaru, CEO for Lift & Co. “There is a land grab opportunity for brands to strategically position their edibles, extracts and topicals products in the second year of legalization. Lift & Co. continues to provide unique consumer data insights by aggregating data across our proprietary consumer database at lift.co and our budtender training platform CannSell.”

Consumers are likely to face challenges understanding what new formats are being introduced to the legal market as well as what new products they may see on shelves. Helping consumers understand these new product formats is challenging because there is variability in some of the naming conventions. For example, Lift & Co. staff found different terminology across different websites.

What’s it called?
Common name Flower / Bud Cannabis Oil* Edibles Beverages Capsules Concentrate (liquid) Concentrate (solid) Topicals
Canada.ca/Cannabis Dried Flower Cannabis Oil Edible cannabis (solid) Edible cannabis (beverage) Cannabis Extract (injested) Cannabis Extract (inhaled) Cannabis Extract (THC concentrate) Cannabis Topicals
Cannabis Act Name
(Schedule 3)
Dried Cannabis Cannabis Oil Solid containing cannabis non-solids containing cannabis non-solids containing cannabis cannabis non-solid concentrates cannabis solid concentrates non-solids containing cannabis
OCS Product Category Dried Flower Cannabis Oil Edibles Beverages Capsules Concentrates Extracts Topicals
*  According to the Government of Canada’s “FINAL REGULATIONS FOR NEW CANNABIS PRODUCTS: EDIBLE CANNABIS, CANNABIS EXTRACTS AND CANNABIS TOPICALS,” Cannabis oil is scheduled to be discontinued as its own product format 12 months after legalization of other formats (October 17, 2020 if legalization is October 17, 2019)
 

For new cannabis consumers who may be trying dried flower and cannabis oil for the first time, understanding how these new product formats compare is difficult. Schedule 3 of the Cannabis Act lays out dried flower equivalents in terms of grams, which is what consumers need to know to calculate their personal public possession limits. The new regulations also set limits for licensed producers and manufacturers for the maximum amount of THC in each of these new product formats. The limits, and the way in which THC is presented on the label differ widely by format making it difficult to compare the amount of THC in a product.

An infographic accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4583fd9d-7466-4449-b503-97241c29ebc8

It is important for consumers to understand that the method of consuming cannabis matters. Inhaling cannabis by smoking or vaping is different than consuming cannabis by eating or drinking it. When cannabis is eaten it is processed by the liver (not the lungs) and is converted into 11-Hydroxy-THC which can have effects on the brain that are up to 3-5 times stronger than regular THC1. This means that edibles can have stronger effects even at lower concentrations.

Expert commentary available

Lift & Co. CEO Matei Olaru and VP Strategy Nick Pateras are available for commentary on what these changes will mean for consumers and the cannabis industry (both in Canada and globally) and can speak to what new product formats we are likely to see.

For commentary on consumer trends and how marketers might position these new product formats our Chief Revenue Officer Jon Kamin is available.

Our CannSell retail training experts are also available for detailed retail and consumer awareness commentary.

About Lift & Co.
Lift & Co. (TSXV: LIFT) (OTCQB: LFCOF) is a publicly traded technology company modernizing the cannabis industry.

Forward-looking statements
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

Although the Company has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended.

There can be no assurance that such forward-looking statements will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. The Company disclaims any intention or obligation to update or revise such information, except as required by applicable law, and the Company does not assume any liability for disclosure relating to any other company mentioned herein.

For further information:
Lift & Co.
Sara McMillen, Director Communications and Government Relations, Lift & Co.
smcmillen@lift.co
1-416-220-9536

Nikki Laoutaris, Communications Manager, Lift & Co.
nlaoutaris@lift.co
1-647-464-0148

Investor Relations:
Thesis Capital
Prit Singh, 905-510-7636, psingh@thesiscapital.ca

____________
1 User-friendly source: https://sapiensoup.com/images/thc/Infographic-Human-Metabolism-THC-1300.png

Original research here: https://www.researchgate.net/profile/Bhola_Nath_Dhawan/publication/20324783_Drug_abuse_in_India_progress_in_research/links/02e7e52a07f8f5d62b000000/Drug-abuse-in-India-progress-in-research.pdf#page=105
And here: https://www.researchgate.net/profile/Franjo_Grotenhermen/publication/10846458_Grotenhermen_F_Pharmacokinetics_and_pharmacodynamics_of_cannabinoids_Clin_Pharmacokinet_42_327-360/links/0deec52c807847f92e000000.pdf 

Continue Reading

IT Industry

AppTech Corp. Terminates LOI to Acquire Alliance Financial Network, Inc.

GlobeNewswire

Published

on

Reading Time: 1 minute

CARLSBAD, Calif., June 14, 2019 (GLOBE NEWSWIRE) — AppTech Corp. (OTC PINK SHEETS: APCX) announces it has terminated the letter of intent to acquire 100% of the equity, liabilities, and subsidiaries of Alliance Financial Network, including eXPO™.

AppTech Corp continues to work with multiple companies to acquire technology that will enhance development for their multiple payment platforms.

For more information about AppTech, please visit www.apptechcorp.com.

About AppTech

AppTech Corp. is a FinTech company providing electronic payment processing technologies and merchant services. The company recently expanded its core services to include global SMS patented text messaging and secure mobile payments based on multi-factor authentication technology.

Forward-Looking Statements

This press release contains forward-looking statements that are inherently subject to risks and uncertainties. Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “forecast”, “intend”, “may”, “plan”, “project”, “predict”, “should” and “‘will” and similar expressions as they relate to AppTech are intended to identify such forward-looking statements. These forward-looking statements involve risks and uncertainties concerning the Company. Actual events or results may differ materially from those described in this press release due to a number of factors. AppTech is under no obligation to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Media Contact
(760) 707-5959
media@apptechcorp.com

Investor Relations Contact
(760) 707-5955
ir@apptechcorp.com

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Follow our Tweets

Trending

Please turn AdBlock off